Harvard Bioscience
company in Holliston, United States
HBIO Nasdaq
ISIN US4169061052 SEC CIK 1123494 LEI 549300VLGB1D47GGC642
Follow Harvard Bioscience
Weekly email: filings, results
Revenue, last quarter
$22.2M
+7.8% vs same quarter last year
Net income
−$2.6M
−113.1% vs same quarter last year
EPS, diluted
−$0.58
−107.1% vs same quarter last year
Operating cash flow
−$248K
−122.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $86.6M | −$56.7M |
| FY24 | $94.1M | −$12.4M |
| FY23 | $112.3M | −$3.4M |
| FY22 | $113.3M | −$9.5M |
| FY21 | $118.9M | −$288K |
| FY20 | $102.1M | −$7.8M |
| FY19 | $116.2M | −$4.7M |
| FY18 | $120.8M | −$2.9M |
| FY17 | $77.4M | −$865K |
| FY16 | $104.5M | −$4.3M |
| FY15 | $108.7M | −$19M |
| FY14 | $108.7M | $2.4M |
| FY13 | $105.2M | −$1.8M |
| FY12 | $111.2M | $2.4M |
| FY11 | $108.9M | $3.8M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 57.7% | −56.1% | −65.5% |
| FY24 | 58.2% | −6.6% | −13.2% |
| FY23 | 58.9% | 1.7% | −3% |
| FY22 | 53.7% | −6.1% | −8.4% |
| FY21 | 56.9% | 1.7% | −0.2% |
| FY20 | 56.8% | 0.2% | −7.6% |
| FY19 | 55.4% | 0.3% | −4% |
| FY18 | 52.3% | 0.8% | −2.4% |
| FY17 | 50.6% | −0.8% | −1.1% |
| FY16 | 46.3% | −2.9% | −4.1% |
| FY15 | 44.8% | −1.6% | −17.5% |
| FY14 | 45.4% | 6.1% | 2.2% |
| FY13 | 45.4% | 1.5% | −1.7% |
| FY12 | 47.1% | 7% | 2.1% |
| FY11 | 46.1% | 7.7% | 3.5% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $5.5M |
| FY24 | −$1.2M |
| FY23 | $12.2M |
| FY22 | −$438K |
| FY21 | $67K |
| FY20 | $8.2M |
| FY19 | $6.8M |
| FY18 | $1.9M |
| FY17 | $167K |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- Harvard Bioscience
- Technology median
Show the numbers
| Year | Harvard Bioscience | Technology median |
|---|---|---|
| FY25 | −65.5% | −2.4% |
| FY24 | −13.2% | −5% |
| FY23 | −3% | −6.7% |
| FY22 | −8.4% | −4.4% |
| FY21 | −0.2% | −1.7% |
| FY20 | −7.6% | −3% |
| FY19 | −4% | 0% |
| FY18 | −2.4% | 0.8% |
| FY17 | −1.1% | 2% |
| FY16 | −4.1% | 2.3% |
| FY15 | −17.5% | 3.1% |
| FY14 | 2.2% | 2.9% |
| FY13 | −1.7% | 3.9% |
| FY12 | 2.1% | 3.9% |
| FY11 | 3.5% | 5.7% |